Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and commercializing life-changing treatments for people with serious, challenging and under-addressed disorders. The company’s diverse portfolio includes four FDA-approved treatments as well as clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms. For more information, visit neurocrine.com, and follow the company on LinkedIn.
Resources:
- INGREZZA® HCP Website: https://www.ingrezzahcp.com/
- INGREZZA® Prescribing Information: https://www.neurocrine.com/assets/INGREZZA_Prescribing_Information.pdf
- INGREZZA® YouTube Channel:
https://www.youtube.com/channel/UCqU_SUeTKcZ-XlyZ2jpXajA - Corporate: https://www.neurocrine.com/